WWE/MMA News: Brock Lesnar fails his second consecutive drug test; suspect unchanged
As noted before, Brock Lesnar was flagged by the US Anti-Doping Agency for a potentially using PEDs following his UFC 200 win. It was said that Lesnar tested positive in the out-of-the competition drug test in which the samples were taken on June 28th .
Now UFC has announced that the Beast has also tested positive in the second in-competition drug test whose samples were taken 12 hours before the UFC 200 event. They announced the news with the following press release:
"The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed.
The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas. Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward."
While UFC has not disclosed the substance which was found in Brock’s samples, wrestlinginc.com is reporting that the former world champion tested positive for the estrogen blocker Clomiphene.
It's said to be a drug commonly used by athletes to reduce estrogen levels while cycling off of PEDs. It's notable here that after the second test, a possible action by UFC against Brock is almost certain and the former Heavyweight Champion could face a 2-year ban from MMA as well as a big fine.